首页> 外文会议>International Photodynamic Association World Congress >LIGHT EMITTING FABRICS FOR PHOTODYNAMIC TREATMENT OF VULVAR PRIMARY EXTRAMAMMARY PAGET'S DISEASE
【24h】

LIGHT EMITTING FABRICS FOR PHOTODYNAMIC TREATMENT OF VULVAR PRIMARY EXTRAMAMMARY PAGET'S DISEASE

机译:外阴原发性疾病的光动力治疗发光织物

获取原文

摘要

Primary Extramammary Paget's disease (EMPD) is a rare cancer that mainly affects the genital region including vulvar and perianal areas. Without treatment, vulvar EMPD progresses and presents always more erythematous and pruritic plaques, which may become ulcerated and erosive. To control disease progression and symptoms usually experienced by patients, surgical excision is the mainstay of treatment. Unfortunately, even after large surgical excision with intra-operative margin control, recurrences are common [1]. For recurrent patients which undergo multiple resections, severe functional and sexual alterations are described. Only few data are available on the efficacy of alternative conservative treatments, such as laser ablation, radiotherapy, topical chemotherapy and photodynamic therapy (PDT) [2]. To date, none of them can be considered as a solid alternative to surgical excision yet [3]. Nonetheless, multiple clinical cases suggest that PDT could provide the opportunity to treat subclinical lesions, and give some relief on patient's symptoms of the disease [4-6]. Unfortunately, the benefits of using photodynamic therapy for vulvar EMPD remains a challenge to demonstrate, because of the inhomogeneous illumination of vulvar and perianal areas, and the extreme pain that patients usually experienced during the illumination procedure that may lead to premature end of treatment [7, 8]. Resulting from the knowledge of previous works on actinic keratosis of the scalp treatment with PDT, light emitting fabrics (LEF) technology could address both of the hereinbefore described issues [9-12]. A new medical device based on LEF named PAGETEX? dedicated to illumination of vulvar and perianal areas has been developed. The device delivers a homogeneous red light (635 nm) with a low irradiance during 2h30, for a total fluence of 12 J/cm~2. The PAGETEX? device is being assessed in a clinical study (NCT03713203) which aims to establish PAGETEX?-PDT efficacy and tolerability.
机译:原发性疾病Paget的疾病(EMPD)是一种罕见的癌症,主要影响包括外阴和围岩地区的生殖器区。没有治疗,外阴EMPD进展并呈现出更加明显和瘙痒斑块,这可能变得溃疡和腐蚀性。为了控制患者通常经历的疾病进展和症状,手术切除是治疗的主干。不幸的是,即使在具有术中的术间隔内控制的大型手术切除后,复发是常见的[1]。对于经历多次切除切除的经常性患者,描述了严重的功能和性改变。只有很少的数据可以获得替代保守治疗的疗效,例如激光烧蚀,放射治疗,局部化疗和光动力治疗(PDT)[2]。迄今为止,它们都不可以被视为手术切除的固体替代方法[3]。尽管如此,多个临床案例表明PDT可以提供治疗亚临床病变的机会,并对患者的疾病症状进行一些缓解[4-6]。不幸的是,由于外阴和围巾区域的不均匀照射,使用光动力学治疗对外阴EMPD的益处仍然是一个挑战,以及患者在可能导致治疗过早的照明程序中经历的患者通常经历的极度疼痛[7 8]。由先前作品的知识与PDT的头皮治疗的光学晶状体化,发光织物(LEF)技术可以解决上文所描述的问题[9-12]。基于名为Pagetex的新医疗设备?致力于发挥外阴和围架地区的照明。该器件在2H30期间提供具有低辐照度的均匀红光(635nm),总使用12J / cm〜2。 Pagetex?在临床研究(NCT03713203)中正在评估设备,其旨在建立pagetex?-pdt功效和耐受性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号